Massive Bio and GELL Partnership | Lucid Diligence Brief
Massive Bio and GELL have launched a strategic partnership to expand AI-enabled…
Public Health Strategic Roundup | June 11–July 15, 2026
Key Strategic Developments Shaping Public Health Coverage: June 11–July 15,…
Public Health Today—July 3, 2026
This week's public health update covers advances in infectious disease…
Lucid Diligence Brief: Insilico and Human Longevity collaboration
Lucid Diligence Brief: Insilico Medicine and Human Longevity collaborate on AI…
Lucid Diligence Brief: NeuroXT and BIDMC Expand Alzheimer’s AI Imaging Collaboration
Lucid Diligence Brief: NeuroXT and BIDMC expand their Alzheimer’s AI imaging…
Public Health Today—May 8, 2026
This weekly update in public health and biomedicine highlights emerging…
Lucid Diligence Brief: Lucent Diagnostics and Tempus AI Partnership
Lucid Diligence Brief: Lucent Diagnostics and Tempus AI Partnership…
Lucid Diligence Brief: Arrowhead ARO-PNPLA3 licensed to Madrigal
Lucid Diligence Brief: Arrowhead ARO-PNPLA3 licensed to Madrigal Professional…
Lucid Diligence Brief: Greywolf Therapeutics and Genomics strategic partnership
Lucid Diligence Brief: Greywolf Therapeutics and Genomics strategic……
Lucid Diligence Brief: Telix / Regeneron radiopharma collaboration
Lucid Diligence Brief: Telix / Regeneron radiopharma collaboration Professional…
Public Health Today—March 20, 2026
This weekly public health update highlights recent developments across clinical…
ESGO 2026 Preview: Key Gynaecological Oncology Highlights to Watch
ESGO 2026 at a Glance Get ready for ESGO 2026. LucidQuest’s preview brings…